Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 27, 2021

SELL
$93.66 - $139.27 $174,207 - $259,042
-1,860 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$116.57 - $155.01 $11,657 - $15,501
-100 Reduced 5.1%
1,860 $245,000
Q3 2020

Oct 19, 2020

SELL
$72.92 - $102.01 $298,972 - $418,241
-4,100 Reduced 67.66%
1,960 $200,000
Q2 2020

Aug 05, 2020

SELL
$55.75 - $92.75 $5,575 - $9,275
-100 Reduced 1.62%
6,060 $527,000
Q1 2020

Apr 28, 2020

SELL
$37.9 - $104.44 $60,640 - $167,104
-1,600 Reduced 20.62%
6,160 $357,000
Q4 2019

Feb 04, 2020

SELL
$77.66 - $99.74 $7,766 - $9,974
-100 Reduced 1.27%
7,760 $718,000
Q3 2019

Oct 17, 2019

BUY
$90.37 - $122.49 $38,407 - $52,058
425 Added 5.72%
7,860 $710,000
Q2 2019

Aug 08, 2019

BUY
$89.51 - $118.04 $665,506 - $877,627
7,435 New
7,435 $863,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.